Blue Owl Capital Holdings LP Eledon Pharmaceuticals, Inc. Transaction History
Blue Owl Capital Holdings LP
- $231 Million
- Q3 2025
A detailed history of Blue Owl Capital Holdings LP transactions in Eledon Pharmaceuticals, Inc. stock. As of the latest transaction made, Blue Owl Capital Holdings LP holds 979,912 shares of ELDN stock, worth $1.72 Million. This represents 1.1% of its overall portfolio holdings.
Number of Shares
979,912
Previous 1,329,912
26.32%
Holding current value
$1.72 Million
Previous $3.6 Million
29.86%
% of portfolio
1.1%
Previous 1.95%
Shares
4 transactions
Others Institutions Holding ELDN
# of Institutions
89Shares Held
32.2MCall Options Held
0Put Options Held
360K-
Bvf Inc San Francisco, CA6.29MShares$11.1 Million0.88% of portfolio
-
Ra Capital Management, L.P. Boston, MA3.57MShares$6.28 Million0.16% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.27MShares$5.75 Million0.0% of portfolio
-
Siren, L.L.C. New York, NY2.07MShares$3.65 Million0.21% of portfolio
-
Zimmer Partners, LP New York, NY1.83MShares$3.21 Million0.13% of portfolio
About Eledon Pharmaceuticals, Inc.
- Ticker ELDN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 13,756,800
- Market Cap $24.2M
- Description
- Eledon Pharmaceuticals, Inc., clinical stage biopharmaceutical company, focuses on developing medicines for the patients living with autoimmune disease and amyotrophic lateral sclerosis (ALS), and requiring an organ or cell-based transplant. Its lead product candidate includes AT-1501, a humanized monoclonal antibody to target CD40 Ligand that i...